Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023380 (
lethargy
)
5,697
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Technical grade milbemycin (A3-A4 oxime) was formulated in propylene glycol to produce a stock concentration of 5.0 mg/ml. Groups of six pond-reared freshwater angelfish (Pterophyllum scalare) randomly housed in 32-L aquaria were exposed to milbemycin by prolonged bath at 63, 125, and 188
PPB
or by its incorporation into their gelatinized food at 2.5 mg or 5.0 mg/100 g food, which they were fed ad lib. for 1 day. Control fish were exposed to a prolonged bath (24 hr without charcoal filtration) of 0.8 ml propylene glycol/32 L water, were given gelatinized food incorporating 1 ml propylene glycol/100 g food ad lib. for 1 day, or were untreated (no propylene glycol exposure). All fish treated at 188
PPB
and the smallest individuals from the 63- and 125-
PPB
aquaria died. Other fish at 125
PPB
exhibited transient
lethargy
and increased opercular movement but recovered within 24 hr. No deleterious effects were noted in the fish given milbemycin orally. Pretreatment parasitic nematode infection rate, evaluated by gut dissection of 16 randomly selected fish, was 68.75%. Identification of nematodes to species was not performed. No significant differences in infection rates between treated and untreated groups were detected.
...
PMID:Safety of milbemycin as an oral or bath treatment for the tropical freshwater angelfish Pterophyllum scalare. 922 22